A detailed history of North Crest Asset Manangement, LLC transactions in Pfizer Inc stock. As of the latest transaction made, North Crest Asset Manangement, LLC holds 56,066 shares of PFE stock, worth $1.54 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
56,066
Previous 58,853 4.74%
Holding current value
$1.54 Million
Previous $1.65 Million 1.46%
% of portfolio
0.05%
Previous 0.06%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$27.7 - $31.39 $77,199 - $87,483
-2,787 Reduced 4.74%
56,066 $1.62 Million
Q2 2024

Jul 16, 2024

SELL
$25.26 - $29.6 $14,044 - $16,457
-556 Reduced 0.94%
58,853 $1.65 Million
Q1 2024

Apr 15, 2024

BUY
$25.89 - $29.73 $161,061 - $184,950
6,221 Added 11.7%
59,409 $1.65 Million
Q4 2023

Jan 30, 2024

SELL
$26.13 - $33.94 $11.6 Million - $15.1 Million
-443,915 Reduced 89.3%
53,188 $1.53 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $754,949 - $882,460
-23,526 Reduced 4.52%
497,103 $16.5 Million
Q2 2023

Jul 21, 2023

BUY
$36.12 - $41.79 $285,817 - $330,684
7,913 Added 1.54%
520,629 $19.1 Million
Q1 2023

Apr 25, 2023

BUY
$39.39 - $51.28 $19.4 Million - $25.3 Million
493,170 Added 2523.12%
512,716 $20.9 Million
Q4 2022

Feb 01, 2023

SELL
$41.75 - $54.5 $17.1 Million - $22.3 Million
-408,841 Reduced 95.44%
19,546 $1 Million
Q3 2022

Oct 17, 2022

BUY
$43.76 - $53.42 $795,119 - $970,641
18,170 Added 4.43%
428,387 $18.7 Million
Q2 2022

Jul 18, 2022

BUY
$46.53 - $55.17 $253,635 - $300,731
5,451 Added 1.35%
410,217 $21.5 Million
Q1 2022

Apr 18, 2022

BUY
$45.75 - $56.69 $17.9 Million - $22.2 Million
391,194 Added 2882.36%
404,766 $21 Million
Q4 2021

Feb 09, 2022

BUY
$41.32 - $61.25 $560,795 - $831,285
13,572 New
13,572 $801,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track North Crest Asset Manangement, LLC Portfolio

Follow North Crest Asset Manangement, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Crest Asset Manangement, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Crest Asset Manangement, LLC with notifications on news.